Rationale and objectives The 5-HT 2A and 5-HT 2C receptors have been shown to be differentially involved in modulating cocaine-induced behaviors. In this study we investigated the effects of the 5-HT 2A antagonist MDL100907 (0.3 mg/kg, i.p.) and the 5-HT 2C antagonist SB242084 (0.5 mg/kg, i.p.) on development, expression, and recall of cocaine-induced conditioned place preference (CPP) in high-(HR) and lowresponder (LR) rats to novelty. Results First, we examined the effects of MDL100907 and SB242084 on development of cocaine-induced CPP. Our results indicated that LR, but not HR, animals conditioned with SB242084+cocaine showed a significantly higher CPP response than controls. This effect was long lasting, as it was still present 30 days after the last conditioning session. Second, we investigated the acute effects of MDL100907 and SB242084 on CPP expression 24 h after cocaine conditioning. Again, our data showed that SB242084 significantly enhanced the expression of cocaine CPP in LR, but not HR animals. Finally, we studied the acute effects of MDL100907 and SB242084 on CPP recall 30 days after cocaine conditioning. Neither MDL100907 nor SB242084 significantly affected the CPP response regardless of the rats' behavioral phenotype. Conclusions This is the first study investigating the contribution of 5-HT 2A and 5-HT 2C receptors on development, expression, and recall of cocaine-induced CPP in the HR-LR model of individual vulnerability to drug abuse. Our results show that SB242084 differentially modulates development and expression of CPP in HR vs. LR rats and suggest that 5-HT 2C receptors play a key role in individual differences on cocaine reward-related learning/memory processes.
Introduction
The serotonin receptor family is an important modulator of the behavioral responsiveness to cocaine. To date, several serotonin receptor subtypes have been described and two receptors of the 5-HT 2 family, the 5-HT 2A and the 5-HT 2C receptors, seem to be particularly involved in regulating cocaine-associated behaviors (Burmeister et al. 2004; Filip et al. 2006; Fletcher et al. 2002; Grottick et al. 2000) . These receptors are distributed throughout the brain, including nuclei of the mesolimbic dopamine (DA) circuits (Clemett et al. 2000; Cornea-Hebert et al. 1999; Eberle-Wang et al. 1997) and their functions in the CNS and addiction-related behaviors have been the subject of several studies in recent years. By contrast, the third receptor of the 5-HT 2 family, the 5-HT 2B receptor, is not highly expressed in the CNS and typically has minimal effects on cocaine-evoked behaviors (Filip et al. 2004 (Filip et al. , 2006 Fletcher et al. 2002) . Preclinical studies have demonstrated that 5-HT 2A and 5-HT 2C receptors have different and often opposite effects on various cocaine-induced behaviors Cunningham 2006, 2008; Filip et al. 2006; Fletcher et al. 2002) . For example, the selective 5-HT 2A antagonist MDL100907 attenuates locomotor activity elicited by cocaine, whereas the selective 5-HT 2C antagonist SB242084 potentiates this cocaine effect (Fletcher et al. 2002) . Moreover, blockade of the 5-HT 2A receptors by ketanserin or MDL100907 attenuates cue-induced reinstatement of cocaine-seeking behavior (Burmeister et al. 2004; Nic Dhonnchadha et al. 2009; Pockros et al. 2011) in the absence of any comparable effect induced by SB242084 (Burmeister et al. 2004 ). On the other hand, agonist stimulation of the 5-HT 2C receptors decreases both cue-and cocaine-primed reinstatement (Burbassi and Cervo 2008; Neisewander and Acosta 2007) .
Addictive drugs can be both "rewarding" (interpreted by the brain as intrinsically positive) and "reinforcing" (behaviors associated with such drugs tend to be repeated) (Hyman and Malenka 2001; White 1989) . Cocaine-induced reward can be assessed by conditioned place preference (CPP), a behavioral paradigm that is thought to model the critical role that environmental cues associated to the drug administration exert over the behavior in cocaine users (Bardo et al. 1995; Tzschentke and Schmidt 1998) . The process of association between the drug and experiential aspects of drug use is driven by Pavlovian (classical) learning, and nowadays there is a growing recognition and interest in understanding the biological and behavioral mechanisms underlying the encoding of drug-related memories (Nic Dhonnchadha and Cunningham 2008) . A large body of evidence is also suggesting that individual differences play an important role in determining the risks to drug abuse. For example, differences in reactivity to a novel environment have been reported to predict cocaine self-administration (Piazza et al. 2000) . These models have also proved to be useful in studying differential responses to pharmacological agents in relation to the treatment of drug addiction. However, whether or not 5-HT 2A and 5-HT 2C receptors contribute to individual differences in cocaine-induced CPP in rats has not been addressed.
In the present study, we classified outbred SpragueDawley male rats as high (HR) and low responders (LR) based on the median split of their locomotor activity in a novel environment. The set of experiments were performed to investigate possible HR-LR differences in: (1) the effects of repeated administration of the 5-HT 2A antagonist MDL100907 or the 5-HT 2C receptor antagonist SB242084 on development of cocaine-induced CPP, (2) the acute effects of these antagonists on expression of the CPP 24 h after the last conditioning trial, in the absence of cocaine, and (3) the effects of the these antagonists on retention of the cocaineinduced CPP 30 days after the conditioning phase.
Materials and methods

Animals
A total of 203 adult male Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA, USA), weighing approximately 225-250 g upon arrival, were used. Animals were housed two per cage in a room adjacent to the testing room and maintained on a 12/12 h light/dark cycle (lights on at 1600 hours). Housing was located in a temperature-and humidity-controlled environment. Rats were acclimated to the animal quarters for 1 week before any experimental procedure and were then conditioned and tested during the dark phase of the cycle. Food and water were available ad libitum. Animals were treated in accordance with National Institutes of Health guidelines on laboratory animal use and care.
Drugs
Cocaine hydrochloride was obtained from Mallinckrodt Inc. (St Louis, MO, USA). SB242084 (6-Chloro-2,3-dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl) oxy]-3-pyridinyl]-1H-indole-1-carboxyamide dihydrochloride) was purchased from Tocris (Ellisville, MO, USA).
ethyl]-4-piperidinemethanol) was purchased from Axon Medchem (Groningen, Netherlands). Cocaine HCL was dissolved in 0.9% saline, while MDL100907 and SB242084 were daily dissolved in saline containing 8.0% hydroxypropyl-β-cyclodextrin. All drugs were injected i.p. at a volume of 1 ml/kg.
Apparatus
Locomotor activity test
After 7 days of habituation to the housing conditions, animals were tested for locomotor activity during a 60-min exposure to the mild stress of a novel environment. Each rat was placed in a 43 L×21.5 W×24.5 H (in centimeter) clear acrylic activity monitor and locomotor activity was monitored by means of two banks of photocells connected to a microprocessor. Rats that exhibited locomotor counts in the higher half of the sample were classified as HR, whereas rats that exhibited locomotor counts in the lower half of the sample were classified as LR. After animals were defined as HR and LR, assignment to individual treatments for each experiment was counterbalanced based on activity levels. This design ensured that each treatment group had animals representative of the range of locomotor activity in the HR and LR groups. One week after the locomotor activity test, HR and LR animals were trained in the place preference paradigm.
Place preference test
The place preference conditioning apparatus consisted of an 80 L×40 W×45H (in centimeter) box equally divided into two compartments by a removable door in the middle. The first compartment had a smooth clear Plexiglas floor and spots on the walls. The second compartment had a rough metallic floor and black stripes on the walls. During conditioning and testing, the entire room was illuminated by a red light from the ceiling, and a single lamp reflecting white light off one wall of the room.
The place preference conditioning consisted of three phases: preconditioning, conditioning, and test (Mueller and Stewart 2000) . During the preconditioning phase, all animals received a single preexposure test in which they were placed in the place preference apparatus and allowed to explore both compartments of the box for 15 min. The placement of the animals in the apparatus was counterbalanced, that is, half of the animals in each group (HR and LR) were initially placed in one side of the apparatus, while the remaining half was placed in the other side. The amount of time spent on each side was monitored and used to assess unconditioned preferences for each individual rat. The unconditioned preference for one or other compartment of the apparatus was evenly distributed across the rat population. One animal showing a strong preference (more than 85% of the session time) for a particular side was eliminated from the study. The least preferred compartment for each rat was then assigned to be the cocaine-paired environment during conditioning (biased design) (Calcagnetti and Schechter 1993; Prus et al. 2009 ). In addition, the number of complete transitions from one chamber to the other was recorded.
During the conditioning phase (8 days), cocaine (COC) was administered in a dose of 20 mg/kg, i.p. once every other day, immediately before the rats were placed into the assigned chamber for 30 min. On alternate days, rats received saline injections (SAL, 1 ml/kg) before being placed in the other chamber. The order of COC-and SAL pairings was counterbalanced so that half of the animals in each group started the conditioning phase with cocaine while the remaining half of the group started with saline.
Twenty-four hours after the last conditioning trial, a test for CPP was given. HR and LR animals were given free access to both compartments and the amount of time spent on each side of the apparatus was monitored for 15 min. Each animal was initially placed in the same side of the apparatus as during the preconditioning phase. The difference in the time spent in the COC-paired compartment during the testing phase versus the preconditioning phase served as an index of place preference. To assess individual differences in the maintenance of the CPP, two additional tests were given 15 and 30 days after the last conditioning trial. The number of complete transitions from one chamber to the other was recorded during tests as an indirect index of locomotion. No COC injections were given on the days of testing, maintaining the same procedure that was used during the preconditioning phase. During the interim period between tests, animals were left undisturbed in their home cages.
Experimental procedures
Effects of repeated administration of MDL100907 or SB242084 on development of COC-induced CPP Animals were tested for CPP 1, 15 and 30 days following the last conditioning trial. Moreover, since other studies have shown that pharmacological manipulation of the 5-HT 2A and 5-HT 2C receptors results in alteration of food intake in rodents (Hayashi et al. 2005; Kennett et al. 1997; Maurel et al. 1999; Thomsen et al. 2008; Vickers et al. 2001) , the potential effect of MDL100907 or SB242084, alone or followed by cocaine, on body weight was monitored through the conditioning phase (1-8 days).
MDL100907 treatment Twenty-seven rats were separated according to their locomotor activity and used for this experiment. After preconditioning, animals in both HR and LR groups received the following treatment during the conditioning phase: MDL100907 (0.3 mg/kg, i.p.)-cocaine or vehicle (saline containing 8.0% hydroxypropyl-β-cyclodextrin, 1 ml/kg)-cocaine (n=6-7 per group). Pretreatments were administered 30 min before cocaine (20 mg/kg, i.p.) (Fletcher et al. 2002; Nic Dhonnchadha et al. 2009 ).
SB242084 treatment Twenty-nine animals were separated in HR and LR and used for this experiment. After preconditioning, animals in both HR and LR groups received the following treatment during the conditioning phase: SB242084 (0.5 mg/kg, i.p.)-cocaine or vehicle (saline containing 8.0% hydroxypropyl-β-cyclodextrin, 1 ml/kg, i.p.)-cocaine (n=6-9 per group). Pretreatments were administered 30 min before cocaine (20 mg/kg, i.p.) (Burmeister et al. 2004; Fletcher et al. 2002 Fletcher et al. , 2006 Fletcher et al. , 2008 Nic Dhonnchadha et al. 2009 ).
Effects of MDL100907 or SB242084 on CPP acquisition in absence of cocaine Forty animals were separated according to their locomotor activity and used to test the potential conditioning effects induced by MDL100907 and SB242084 when administered alone and to control for changes in place preference that might spontaneously occur over time. After preconditioning, HR and LR animals were divided into three treatment groups: MDL100907 (0.3 mg/kg, i.p.)-saline, SB242084 (0.5 mg/kg, i.p.)-saline and vehicle (saline containing 8.0% hydroxypropyl-β-cyclodextrin, 1 ml/kg, i.p.)-saline (n=5 per group). A fourth treatment group, vehicle (saline containing 8.0% hydroxypropyl-β-cyclodextrin, 1 ml/kg, i.p.) followed by cocaine (20 mg/kg, i.p.) was also run in parallel as an internal control for the experiment (n=5 per group). In all cases, pretreatment was followed by treatment 30 min later.
Influence of MDL100907 or SB242084 on the expression of COC-induced CPP Twenty-seven and 35 animals were separated in HR and LR according to their locomotor activity and used to test the potential effects of MDL100907 and SB242084, respectively on expression of cocaine-induced CPP. Following preconditioning phase, all animals were trained in the conditioned place preference paradigm as described above.
MDL100907 treatment Twenty-four hours after the last conditioning trial, animals in both HR and LR groups received the following drug treatment: MDL100907 (0.3 mg/kg, i.p.) or vehicle (saline containing 8.0% hydroxypropyl-β-cyclodextrin, 1 ml/kg, i.p.) (n=6-8 per group) 30 min before the CPP test at T1. As an indirect measure of locomotion, the number of transitions between the two chambers during the test was also monitored.
SB242084 treatment HR and LR groups received the following drug treatment 24 h after the last conditioning trial: SB242084 (0.5 mg/kg, i.p.) or vehicle (saline containing 8.0% hydroxypropyl-β-cyclodextrin, 1 ml/kg, i.p.) (n = 8-11) 30 min before the CPP test at T1. Locomotion activity was also monitored as detailed above.
Effects of MDL100907 or SB242084 on recall of COC-induced CPP
Nineteen and 21 animals were separated in HR and LR according to their locomotor activity and used to test the potential effects of MDL100907 and SB242084, respectively on recall of cocaine-induced CPP. Following preconditioning phase, all animals were trained in the conditioned place preference paradigm and tested for CPP 1 and 15 days after conditioning, as described above.
MDL100907 treatment HR and LR animals were submitted to one of the following treatment conditions 30 days after the last conditioning trial: MDL100907 (0.3 mg/kg, i.p.) or vehicle (saline containing 8.0% hydroxypropyl-β-cyclodextrin, 1 ml/kg, i.p.) (n=4-5 per group). Treatment was administered 30 min before the test for CPP at day 30. A total of three animals, two HR and one LR, showing no COC-induced CPP on the second test (day 15) were excluded from the experiment. The number of transitions between chambers on the day of the test was also monitored.
SB242084 treatment Animals in the HR and LR groups received one of the following treatments 30 days after last conditioning trial: SB242084 (0.5 mg/kg, i.p.) or vehicle (saline containing 8.0% hydroxypropyl-β-cyclodextrin, 1 ml/kg, i.p.) (n=4-6 per group).
Treatment was administered 30 min before the test for CPP at day 30. A total of two animals, one HR and one LR, showing no COC-induced CPP on the second test (day 15) were excluded from the experiment. Locomotion activity was monitored as detailed above.
Statistical analysis
Cocaine-induced CPP was measured as the amount of time spent in the drug-paired chamber on the test day relative to the amount of time spent in the drug-paired chamber during the preconditioning phase. The means are represented as percent change in time during the test relative to preconditioning.
Three-way ANOVAs with repeated measures with phenotype, pretreatment drug, and test or conditioning day as factors were used: to test the effects of MDL100907 and SB242084, alone or with cocaine, on development, expression, and recall of conditioned place preference; to test the effects of the same drugs on changes in body weight; and to control for changes in place preference that might spontaneously occur over time. Two-way ANOVAs with phenotype and pretreatment drug as factors were performed to analyze the effects of the 5-HT 2 antagonists on locomotion as measured by crossings across CPP chambers during testing.
A statistically significant effect was followed by Bonferroni test for post hoc comparisons (acceptable significance level, p<0.05). In addition, independent simple regressions between locomotion score and CPP for each antagonist were also determined.
Results
Locomotor activity Locomotor activity for HR and LR animals used to investigate the effects of MDL100907 and SB242084 on development, expression, and recall of cocaine-induced CPP was 796.5±24.7 and 528.5±27.7 counts, 744.5±25.7 and 427.9±27.6 counts, and 744.9± 28.1 and 420.1±23.2 counts, respectively. Locomotor activity for HR and LR animals used to investigate place preference conditioning in the absence of cocaine was 692.3 ± 31.5 and 431.8 ± 18.3 counts. There were no statistically significant differences between groups of animals of the same phenotype.
Cocaine-induced CPP Overall, the CPP protocol used in our study produced a significant conditioned place preference in both HR and LR animals. In fact, when we combined vehicle + cocaine-treated animals from the experiments investigating the development of cocaine-induced CPP and vehicle-treated animals from the experiments investigating the expression and recall of cocaine-induced CPP, statistical analysis revealed a significant conditioning overall, F(3, 207)=26.83, p<0.0001, as well as a significant interaction between phenotype (HR vs. LR) and test day (preconditioning, T1, T15, and T30) F(3, 207)=2.75, p<0.05. Post hoc comparisons showed that LR animals had significantly lower CPP than individuals in the HR group on test T30 (30 days after the last conditioning trial) (Fig. 1) .
Influence of repeated administration of MDL100907 or SB242084 on development of COC-induced CPP Figure 2a , b shows the effects of MDL100907 or SB242084 on development of COC-induced CPP in HR vs. LR animals. A three-way ANOVA with repeated measures for the effects of MDL100907, where the factors were phenotype (HR vs. LR), pretreatment drug (MDL100907 or vehicle), and test day (preconditioning, T1, T15, and T30), revealed a significant main effect of test day, F(3, 69)=8.06, p<0.001 with no other significant main effects and no significant interactions. Post hoc comparisons revealed a significant increase in the preference response relative to preconditioning during all test days (Fig. 2a) .
A three-way ANOVA with repeated measures for the effects of SB242084 on COC-induced CPP revealed a significant effect of test day, F(3, 75)=17.37, p<0.001, as well as a significant interaction of the three factors (phenotype × pretreatment drug × test day), F(3, 75)=3.36, p<0.05. Post hoc comparisons indicated that LR animals pretreated with SB242084 showed a significant increase in COC-induced CPP on test T1 compared to animals in the same phenotype group pretreated with vehicle. This effect was still detected 30 days after the last conditioning (Fig. 2b) . Moreover, a regression analysis in all animals pretreated with the 5-HT 2C antagonist SB242084 revealed a significant negative correlation between locomotion score and CPP during test T1 (r=0.566, p<0.05) and test T30 (r=0.656, p<0.01).
The effect of SB242084 in LR animals was specific to cocaine-induced CPP. In fact, neither SB242084 nor MDL100907 evoked conditioned place preference when administered alone. Similarly, the vehicle-saline-treated group in the same experiment failed to show any significant changes in place preference over time (Fig. 3) . By contrast, the internal control group for the experiment that was treated with vehicle followed by cocaine (20 mg/kg, i.p.) showed a statistically significant effect, F(1, 8)=16.71, p<0.01 and confirmed that animals could be conditioned under the experimental conditions used.
Finally, a three-way ANOVA for the effects on body weight induced by repeated administration of MDL100907 or SB242084 alone showed a significant effect of conditioning day, F(6, 198)=7.69, p<0.001, indicating that all animals showed a progressive increase in body weight over time regardless of pretreatment drug (data not shown).
Influence of MDL100907 or SB242084 on the expression of COC-induced CPP Figure 4a , b shows the effects induced by MDL100907 or SB242084 on the expression of the CPP associated to cocaine in HR vs. LR animals. A three-way ANOVA with repeated measures for the influence of MDL100907 on CPP expression revealed a significant effect of test day (preconditioning vs. T1), F(1, 23)=28.98, p<0.001, but not significant effects of phenotype or pretreatment drug, nor significant interactions (Fig. 4a) .
By contrast, a three-way ANOVA with repeated measures for the acute effects of SB242084 on CPP expression revealed a significant interaction of all main factors in the analysis (phenotype × pretreatment drug × test day), F(1, 31)=7.29, p<0.05 (Fig. 4b) . Following post hoc comparisons indicated that acute administration of SB242084 significantly enhanced the expression of the CPP in LR, but not HR, animals (Fig. 4b) .
The effects of the 5-HT 2A and 5-HT 2C antagonists on cocaine-induced locomotion were also indirectly determined by analysis of the number of transitions during test T1. While MDL100907 did not have any effect on locomotion, a twoway ANOVA for the effects of SB242084 on conditioned HR vs. LR animals revealed a significant main effect of the pretreatment drug, F(1, 31)=7.93, p<0.01, indicating that overall animals injected with SB242084 had higher number of crossings between chambers than animals pretreated with vehicle.
Influence of MDL100907 or SB242084 on recall of COC-induced CPP Figure 5a , b shows the effects of MDL100907 or SB242084 on recall of the CPP 30 days after the last conditioning trial (test T30) in HR and LR groups. Threeway ANOVAs for MDL100907 or SB242084 revealed no significant main effects of these drugs on CPP recall. Moreover, statistical analysis of the number of crossings in these animals during test T30 indicated that locomotion was not affected by acute administration of these antagonists.
Discussion
Both HR and LR animals revealed a significant CPP for the place associated with cocaine administrations, and this effect was long lasting. Our data agree with earlier studies showing that HR and LR rats do not differ in the cocaineconditioned response as measured by CPP (Erb and Parker 1994; Gong et al. 1996) . However, the present study extends these findings by providing evidence of individual differences in the maintenance of the CPP following a long period of time after the last conditioning trial, as demonstrated Time spent in the cocaine-paired side (%) by a significantly higher place preference in HR than in LR rats on post-conditioning day 30. Our data seem to suggest that long after the drug is withdrawn, individuals that show higher preference for the drug initially are also at risk to relapse in cocaine-seeking behavior when re-exposed to the environmental cues associated with the drug experience. One of the more remarkable findings from this study is that LR animals were overall more susceptible to the effects induced by the selective 5-HT 2C receptor antagonist SB242084 than HR rats. Indeed, repeated coadministration of SB242084+cocaine during the conditioning phase produced a significant increase in the CPP response in LR rats only. Moreover, a negative correlation between locomotion and CPP in animals pretreated with SB242084+cocaine was observed. These effects were present only when SB242084 was coadministered with cocaine. In fact, injection of SB242084 followed by saline did not induce CPP in LR animals. These finding suggests that in our study the 5-HT 2C receptor blockade facilitated the acquisition of cocaineinduced place preference in LR animals by either increasing the efficacy of the cocaine rewarding actions or improving the learning conditions. It is believed that DA neuronal cell firing may encode the incentive value or the prediction of reward (Schultz 1998) . Over recent years, evidence has emerged that suggests that 5-HT 2C receptors may modulate mesocorticolimbic DA release and thus, affect motivation and behavior (Di Matteo et al. 1999; Navailles et al. 2008) . Moreover, using the HR-LR model of individual vulnerability to drugs, different laboratories have shown that increased vulnerability is associated with increases in basal and stimulated DA levels in the NAcc and striatum (Bradberry et al. 1991; Hooks et al. 1991 Hooks et al. , 1992 Piazza et al. 1991; Rouge-Pont et al. 1993 , 1998 . Our data seem to suggest that 5-HT 2C receptors may differentially modulate accumbal DA release in HR vs. LR animals, leading to an enhanced acquisition of the cocaine-conditioned response particularly in LR rats.
In addition to enhancing the hedonic value of cocaine, the inhibition of the 5-HT 2C receptors may have modulated the development of CPP to cocaine by altering the associative learning during drug conditioning. In support of this idea, the 5-HT 2C receptors seem to play a role in other forms of associative learning, such as passive avoidance and autoshaping (Meneses and Hong 1997; Misane and Ogren 2000) .
Acute inhibition of 5-HT 2C receptors affected the expression of cocaine-induced CPP in LR animals. Recent studies have provided evidence that 5-HT 2C receptors control the expression of cocaine-conditioned behaviors (dela Cruz et al. 2009; Liu and Cunningham 2006) Our results, together with previously published studies, suggest a critical role played by 5-HT 2C receptors in improving the expression of cocaine-associated behaviors, perhaps by decreasing thresholds to motivational effects elicited by the environmental cues that were present at the time of cocaine administrations. Of importance, our study provides evidence of a differential role for the 5-HT 2C receptors in the brain of HR and LR rats in the motivational aspects that initiate and maintain cocaine abuse in these animals.
Acute administration of the 5-HT 2A antagonist MDL100907 did not produce significant main effects on expression of CPP in HR or LR groups. However, LR animals seemed to have a lower CPP response as compared to their counterpart vehicle-treated animals. It is possible that the use of different doses of cocaine and/or MDL100907 would have resulted in a decrease of cocaine-induced CPP expression in LR animals that reached significance. In the present study, we also investigated whether or not 5-HT 2A and 5-HT 2C receptors play a role in the expression of cocaine CPP during a retention test 30 days after the last conditioning trial. Our data showed that recall of cocaine-induced produces adaptive changes in the brain that occur after the drug is discontinued. Some of these brain alterations return to basal levels shortly after the drug is discontinued, while others seem to still be present or start taking place after a long period of forced abstinence (Freeman et al. 2008 (Freeman et al. , 2010 . Perhaps, the molecular changes that are responsible for the memory of the association of cocaine-environment and/or the cocaine-induced motivational effects during post-abstinence are different at T1 and T30, and 5-HT 2C receptors are critical during early abstinence but not later. Consistently with this hypothesis, data from our lab have shown different profiles of gene expression in the nucleus accumbens at different durations of abstinence from cocaine self-administration (Capriles et. al. unpublished data) .
The higher susceptibility to the pharmacological manipulations of the 5-HT 2C receptor in LR animals that result in an enhanced conditioned response to cocaine could also be secondary to different pharmacokinetic and pharmacodynamic profiles in the HR and LR phenotypes. In the present study, we have used a single dose of the 5-HT 2A and 5-HT 2C receptor antagonists. The doses were chosen from the literature and have been proven to be effective in affecting various cocaine-associated behaviors (Burmeister et al. 2004; Fletcher et al. 2002 Fletcher et al. , 2006 Fletcher et al. , 2008 Nic Dhonnchadha et al. 2009 ). However, we cannot dismiss shifts in dose-effects curves, and it is possible that administration of cocaine and/or serotonergic antagonists at different doses than the ones used in the study could have uncovered effects on the HR phenotype or shown significant effects after administration of the 5-HT 2A antagonist. It is important to point out though that even if this were the case, our results would still support the finding that LR animals are more vulnerable to pharmacological manipulations of the 5-HT 2C receptors.
To summarize, we have investigated the contribution of 5-HT 2A and 5-HT 2C receptors on development, expression, and recall of cocaine-induced CPP in the HR-LR model of individual vulnerability to drug abuse. The main finding from these set of experiments is that SB242084 differentially modulates development and expression of conditioned place preference in HR vs. LR animals, as demonstrated by the increased vulnerability to 5-HT 2C receptor antagonist properties in the LR phenotype. Therefore, our results suggest that the 5-HT 2C receptors play a key role in individual differences on cocaine reward-related learning/memory processes.
Despite our growing knowledge of the cocaine addiction, a high rate of relapse to drug-seeking behavior is often reported as a consequence of unsuccessful pharmacotherapies. The present data emphasize that a model of individual differences is indeed necessary to characterize the response to potentially useful compounds, such as those affecting the 5-HT 2C receptors, in the treatment of cocaine addicts.
